These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8175757

  • 1. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.
    Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP.
    J Biol Chem; 1994 May 06; 269(18):13273-8. PubMed ID: 8175757
    [Abstract] [Full Text] [Related]

  • 2. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
    Krych M, Hourcade D, Atkinson JP.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4353-7. PubMed ID: 1827918
    [Abstract] [Full Text] [Related]

  • 3. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC, Scesney SM, Ford PJ, Evans KS, Carson GR, Marsh HC.
    J Biol Chem; 1992 Dec 05; 267(34):24754-61. PubMed ID: 1447213
    [Abstract] [Full Text] [Related]

  • 4. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB, Clemenza L, Krych M, Atkinson JP.
    J Immunol; 1996 Aug 01; 157(3):1242-7. PubMed ID: 8757632
    [Abstract] [Full Text] [Related]

  • 5. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT.
    J Exp Med; 1988 Nov 01; 168(5):1699-717. PubMed ID: 2972794
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
    Reilly BD, Makrides SC, Ford PJ, Marsh HC, Mold C.
    J Biol Chem; 1994 Mar 11; 269(10):7696-701. PubMed ID: 8125996
    [Abstract] [Full Text] [Related]

  • 7. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR, Fearon DT.
    J Immunol; 1994 Mar 15; 152(6):2899-903. PubMed ID: 8144890
    [Abstract] [Full Text] [Related]

  • 8. Structure-function analysis of the active sites of complement receptor type 1.
    Krych M, Hauhart R, Atkinson JP.
    J Biol Chem; 1998 Apr 10; 273(15):8623-9. PubMed ID: 9535836
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
    Mossakowska D, Dodd I, Pindar W, Smith RA.
    Eur J Immunol; 1999 Jun 10; 29(6):1955-65. PubMed ID: 10382758
    [Abstract] [Full Text] [Related]

  • 10. Structure-function relationships of complement receptor type 1.
    Krych-Goldberg M, Atkinson JP.
    Immunol Rev; 2001 Apr 10; 180():112-22. PubMed ID: 11414353
    [Abstract] [Full Text] [Related]

  • 11. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
    Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT.
    J Exp Med; 1987 Apr 01; 165(4):1095-112. PubMed ID: 2951479
    [Abstract] [Full Text] [Related]

  • 12. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
    Birmingham DJ, Irshaid F, Gavit KF, Nagaraja HN, Yu CY, Rovin BH, Hebert LA.
    Mol Immunol; 2007 Jul 01; 44(14):3510-6. PubMed ID: 17467802
    [Abstract] [Full Text] [Related]

  • 13. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H, Kinoshita T, Webster CB, Holers VM.
    J Immunol; 1994 Jul 15; 153(2):789-95. PubMed ID: 8021513
    [Abstract] [Full Text] [Related]

  • 14. Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
    Smith BO, Mallin RL, Krych-Goldberg M, Wang X, Hauhart RE, Bromek K, Uhrin D, Atkinson JP, Barlow PN.
    Cell; 2002 Mar 22; 108(6):769-80. PubMed ID: 11955431
    [Abstract] [Full Text] [Related]

  • 15. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S.
    J Biol Chem; 1995 Jun 23; 270(25):15148-52. PubMed ID: 7541036
    [Abstract] [Full Text] [Related]

  • 16. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T, Matsumoto M, Nakanishi I, Yasuda R, Seya T.
    J Biochem; 1992 May 23; 111(5):573-8. PubMed ID: 1386357
    [Abstract] [Full Text] [Related]

  • 17. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
    Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, Perkins SJ.
    J Mol Biol; 2008 Jan 04; 375(1):102-18. PubMed ID: 18028942
    [Abstract] [Full Text] [Related]

  • 18. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A, Yuasa-Nakagawa T, Murakami Y, Funami K, Kishi N, Matsuda T, Fujita T, Seya T, Nagasawa S.
    J Biochem; 2002 Nov 04; 132(5):719-28. PubMed ID: 12417021
    [Abstract] [Full Text] [Related]

  • 19. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR, Hsu PH, Bartow TJ, Ahearn JM, Matsumoto AK, Klickstein LB, Fearon DT.
    J Exp Med; 1991 Dec 01; 174(6):1451-60. PubMed ID: 1836011
    [Abstract] [Full Text] [Related]

  • 20. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).
    Oran AE, Isenman DE.
    J Biol Chem; 1999 Feb 19; 274(8):5120-30. PubMed ID: 9988761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.